Hematopoietic Stem Cell Protocols M E T H O D S I N M O L E C U L A R M E D I C I N ETM John M. Walker, Series Editor 72. Malaria Methods and Protocols, edited 54. Mycobacterium tuberculosis Protocols, edited byDenise L. Doolan, 2002 byTanya Parish and Neil G. Stoker, 2001 71. Hemophilus influenzae Protocols, edited 53. Renal Cancer: Methods and Protocols, byMark A. Herbert, E. Richard Moxon, edited by Jack H. Mydlo, 2001 and Derek Hood, 2002 52. Atherosclerosis: ExperimentalMethods and 70. Cystic Fibrosis Methods and Protocols, Protocols,edited by Angela F. Drew, 2001 edited by William R. Skach, 2002 51. Angiotensin Protocols, edited by Donna 69. Gene Therapy Protocols, 2nd ed., edited H. Wang, 2001 byJeffrey R. Morgan, 2002 50. Colorectal Cancer: Methods and 68. Molecular Analysis of Cancer, edited by Protocols, edited by Steven M. Powell, Jacqueline Boultwood and Carrie Fidler, 2002 2001 67. Meningococcal Disease: Methods and 49. Molecular Pathology Protocols, edited by Protocols,edited by Andrew J. Pollard Anthony A. Killeen, 2001 and Martin C. J. Maiden, 2001 48. Antibiotic Resistance Methods and 66. Meningococcal Vaccines: Methods and Protocols,edited by Stephen H. Gillespie, Protocols,edited by Andrew J. Pollard and 2001 Martin C. J. Maiden, 2001 47. Vision Research Protocols, edited by P. 65. Nonviral Vectors for Gene Therapy: Elizabeth Rakoczy, 2001 Methods and Protocols, edited by Mark A. 46. AngiogenesisProtocols,edited byJ. Findeis,2001 Clifford Murray, 2001 64. Dendritic Cell Protocols, edited by Stephen 45. Hepatocellular Carcinoma: Methods and P. Robinson and Andrew J. Stagg, 2001 Protocols,edited byNagy A. Habib, 2000 63. Hematopoietic Stem Cell Protocols, 44. Asthma:Mechanisms and Protocols, edited by edited by Christopher A. Klug and Craig K. Fan Chung and Ian Adcock, 2001 T. Jordan, 2002 43. Muscular Dystrophy: Methods and 62. Parkinson’s Disease: Methods and Protocols, Protocols,edited byKatherine B. Bushby edited by M. Maral Mouradian, 2001 and Louise Anderson, 2001 61. Melanoma Techniques and Protocols: 42. Vaccine Adjuvants:Preparation Methods Molecular Diagnosis, Treatment, and and Research Protocols, edited by Derek Monitoring,edited by Brian J. Nickoloff, 2001 T. O’Hagan, 2000 60. Interleukin Protocols, edited by Luke A. 41. Celiac Disease: Methods and Protocols, J. O’Neill and Andrew Bowie, 2001 edited by Michael N. Marsh, 2000 59. Molecular Pathology of the Prions, 40. Diagnostic and Therapeutic Antibodies, edited by Harry F. Baker, 2001 edited by Andrew J. T. George and Catherine E. Urch, 2000 58. Metastasis Research Protocols: Volume 2, Cell Behavior In Vitro and In Vivo,edited by 39. Ovarian Cancer: Methods and Protocols, Susan A. Brooks and Udo Schumacher, 2001 edited by John M. S. Bartlett, 2000 57. Metastasis Research Protocols: Volume 1, 38. Aging Methods and Protocols, edited by Analysis of Cells and Tissues, edited by Susan Yvonne A. Barnett and Christopher R. A. Brooks and Udo Schumacher, 2001 Barnett, 2000 56. Human Airway Inflammation: Sampling 37. Electrochemotherapy, Electrogenetherapy, Techniques and Analytical Protocols, edited by and Transdermal Drug Delivery: Duncan F. Rogers and Louise E. Donnelly, 2001 Electrically Mediated Delivery of Molecules 55. Hematologic Malignancies: Methods and to Cells, edited by Mark J. Jaroszeski, Protocols,edited by Guy B. Faguet, 2001 Richard Heller, and Richard Gilbert, 2000 M E T H O D S I N M O L E C U L A R M E D I C I N ETM Hematopoietic Stem Cell Protocols Edited by Christopher A. Klug, PhD University of Alabama-Birmingham, Birmingham, AL and Craig T. Jordan, PhD University of Kentucky, Lexington, KY Humana Press Totowa, New Jersey © 2002 Humana Press Inc. 999 Riverview Drive, Suite 208 Totowa, New Jersey 07512 humanapress.com All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise without written permission from the Publisher. Methods in Molecular Medicine™is a trademark of The Humana Press Inc. All authored papers, comments, opinions, conclusions, or recommendations are those of the author(s), and do not necessarily reflect the views of the publisher. This publication is printed on acid-free paper. (cid:39) ANSI Z39.48-1984 (American Standards Institute) Permanence of Paper for Printed Library Materials. Cover design by: Patricia Cleary Cover photograph: Scanning electron microscope image of a long-term stroma-supported culture of mouse bone marrow cells. The spherical cells are clustered in so-called ‘cobblestone areas’, and their association with stromal cells can be seen in some places. Photo: Julian D. Down and Rob E. Ploemacher. Production Editor: Kim Hoather-Potter For additional copies, pricing for bulk purchases, and/or information about other Humana titles, contact Humana at the above address or at any of the following numbers: Tel: 973-256-1699; Fax: 973-256-8341; E-mail: [email protected]; Website: humanapress.com Photocopy Authorization Policy: Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Humana Press Inc., provided that the base fee of US $10.00 per copy, plus US $00.25 per page, is paid directly to the Copyright Clearance Center at 222 Rosewood Drive, Danvers, MA 01923. For those organizations that have been granted a photocopy license from the CCC, a separate system of payment has been arranged and is acceptable to Humana Press Inc. The fee code for users of the Transactional Reporting Service is [0-89603-812-2/02 $10.00 + $00.25]. Printed in the United States of America. 10 9 8 7 6 5 4 3 2 1 Library of Congress Cataloging in Publication Data Main entry under title: Methods in molecular medicine™. Hematopoietic stem cell protocols / edited by Christopher A. Klug and Craig T. Jordan. p. ; cm. — (Methods in molecular medicine; 63) Includes bibliographical references and index. ISBN 0-89603-812-2 (alk. paper) 1. Hematopoietic stem cells—Laboratory manuals. I. Klug, Christopher A. II. Jordan, Craig T. III. Series. [DNLM: 1. Hematopoietic Stem Cells—cytology. 2. Cytological Techniques—methods. 3. Hematopoietic Stem Cells—physiology. WH 380 H48693 2001] QP92.H4534 2001 611'.41—dc21 2001016559 Preface The ability to highly purify and characterize hematopoietic stem cells (HSC) from mice and humans has opened up an exceedingly rich field of basic science research with enormous clinical potential. Many of the techniques used in stud- ies of HSC biology have become more standardized over the last several years, which makes it possible to compile a set of methods that can be used by both seasoned investigators and novices in the stem cell field. We have attempted to be as comprehensive as possible and yet focus on what we perceive to be the most widely used approaches for studies of murine and human HSC. This first edition of Hematopoietic Stem Cell Protocols will therefore have some obvious omissions that were dictated by contemporary circumstances. It is our hope that readers will feel free to contribute their personal suggestions for further chapters as well as on how existing chapters can be improved for future editions. We certainly expect that old approaches will be refined, new assays will be developed, and other animal model and vector systems will be described that will become the new gold standards for future work. Our sin- cere thanks goes out to all of the contributors and to those in the stem cell field that have enlarged our thinking and provided new tools to further understand this fascinating cell type. Christopher A. Klug, PhD Craig T. Jordan, PhD v Contents Preface .............................................................................................................v Contributors.....................................................................................................ix 1 Isolation and Analysis of Hematopoietic Stem Cells from Mouse Embryos Elaine Dzierzak and Marella de Bruijn................................................1 2 The Purification of Mouse Hematopoietic Stem Cells at Sequential Stages of Maturation Sean J. Morrison..................................................................................15 3 Flow Cytometry and Immunoselection of Human Stem Cells Terry E. Thomas, Sara J. Abraham, and Peter M. Lansdorp.........29 4 Method for Purification of Human Hematopoietic Stem Cells by Flow Cytometry Michael J. Reitsma, Brenda R. Lee, and Nobuko Uchida...............59 5 Noninvasive Measurement of Hematopoietic Stem Cell Cycling and Turnover by In Vivo Bromodeoxyuridine Incorporation Gillian B. Bradford and Ivan Bertoncello.........................................79 6 Isolation and Characterization of Primitive Hematopoietic Cells Based on Their Position in the Cell Cycle Edward F. Srour and Craig T. Jordan...............................................93 7 Hematopoietic Colony-Forming Cells Makio Ogawa and Anne G. Livingston............................................113 8 Long-Term Culture-Initiating Cell Assays for Human and Murine Cells Cindy L. Miller and Connie J. Eaves...............................................123 9 The Cobblestone-Area-Forming Cell Assay Gerald de Haan and Rob Ploemacher.............................................143 10 CFU-S: An Assay for Pluripotent Myelopoietic Stem Cells Ernest A. McCulloch..........................................................................153 11 Intrathymic Injection for Analysis of T-Cell Progenitor Activity Libuse Jerabek and Irving L. Weissman........................................161 vii viii Contents 12 Quantitation of Murine and Human Hematopoietic Stem Cells by Limiting Dilution Analysis in Competitively Repopulated Hosts Stephen J. Szilvassy, Franck E. Nicolini, Connie J. Eaves, and Cindy L. Miller........................................................................167 13 Ex Vivo Expansion of Human and Murine Hematopoietic Stem Cells Cindy L. Miller, Julie Audet, and Connie J. Eaves........................189 14 Hematopoietic Development of ES Cells in Culture Gordon M. Keller, Saiphone Webb, and Marion Kennedy............209 15 Genetic Modification of Murine Hematopoietic Stem Cells by Retroviruses Christian P. Kalberer, Jennifer Antonchuk, and R. Keith Humphries...............................................................231 16 Retroviral Transduction of FACS-Purified Hematopoietic Stem Cells Claudiu V. Cotta, C. Scott Swindle, Irving L. Weissman, and Christopher A. Klug...............................................................243 17 Retroviral-Mediated Transduction and Clonal Integration Analysis of Human Hematopoietic Stem and Progenitor Cells Mo A. Dao and Jan A. Nolta..............................................................253 18 Production of Lentiviral Vector Supernatants and Transduction of Cellular Targets Richard E. Sutton...............................................................................275 19 Reverse Transcriptase-PCR Analysis of Gene Expression in Hematopoietic Stem Cells Donald Orlic........................................................................................287 20 Identification of Differentially Expressed Genes in Sorted Cell Populations by Two-Dimensional Gene-Expression Fingerprinting Alexander V. Belyavsky, Sergey V. Shmelkov, and Jan W. M. Visser.....................................................................301 Index...........................................................................................................327 Contributors SARA J. ABRAHAM•British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada JENNIFER ANTONCHUK•Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada JULIE AUDET • Terry Fox Laboratory, Departments of Chemical and Bio-Resource Engineering, University of British Columbia, Vancouver, British Columbia, Canada ALEXANDER V. BELYAVSKY • New York Blood Center, New York, NY, Engelhardt Institute of Molecular Biology, Moscow, Russia IVAN BERTONCELLO • Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia GILLIAN B. BRADFORD • Howard Hughes Medical Institute, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN CLAUDIU V. COTTA • Department of Pathology, University of Alabama at Birmingham, Birmingham, AL MO A. DAO• Division of Research Immunology/Bone Marrow Transplantation, Children’s Hospital; Departments of Pediatrics and Craniofacial Developmental Biology, Los Angeles, CA MARELLA DE BRUIJN•Department of Cell Biology and Genetics, Erasmus University, Rotterdam, the Netherlands GERALDDE HAAN•Department of Stem Cell Biology, University of Gröningen, Gröningen, the Netherlands ELAINE DZIERZAK • Department of Cell Biology and Genetics, Erasmus University, Rotterdam, the Netherlands CONNIE J. EAVES•Terry Fox Laboratory, British Columbia Cancer Agency, StemCell Technologies Inc., Vancouver, British Columbia, Canada R. KEITH HUMPHRIES•Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada LIBUSE JERABEK• Stanford University School of Medicine, Stanford, CA CRAIG T. JORDAN•Markey Cancer Center, University of Kentucky, Lexington, KY CHRISTIAN P. KALBERER•Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada ix x Contributors GORDON M. KELLER•Department of Medicine, National Jewish Medical and Research Center, Denver, CO MARION KENNEDY•Department of Medicine, National Jewish Medical and Research Center, Denver, CO CHRISTOPHER A. KLUG•Comprehensive Cancer Center, University of Alabama-Birmingham, Birmingham, AB PETER M. LANSDORP•Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada BRENDA R. LEE•SyStemix, Inc., Palo Alto, CA ANNE G. LIVINGSTON • Ralph H. Johnson VA Medical Center, Medical University of South Carolina, Charleston, SC ERNEST A. MCCULLOCH • The Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada CINDY L. MILLER•StemCell Technologies Inc., Vancouver, British Columbia, Canada SEAN J. MORRISON • Departments of Internal Medicine and Cell and Developmental Biology, Howard Hughes Medical Institute and University of Michigan, Ann Arbor, MI FRANCK E. NICOLINI•Terry Fox Laboratory, Vancouver, British Columbia, Canada JAN A. NOLTA • Division of Research Immunology/Bone Marrow Transplantation, Children's Hospital, Departments of Pediatrics and Craniofacial Developmental Biology, Los Angeles, CA MAKIO OGAWA•Ralph H. Johnson VA Medical Center, the Medical University of South Carolina, Charleston, SC DONALD ORLIC•Hematopoiesis Section, Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institute of Health, Bethesda, MD ROB PLOEMACHER • Institute of Hematology, Erasmus University, Rotterdam, the Netherlands MICHAEL J. REITSMA • StemCells Inc., Sunnyvale, CA SERGEY V. SHMELKOV • New York Blood Center, New York, NY, Engelhardt Institute of Molecular Biology, Moscow, Russia EDWARD F. SROUR•Indiana Cancer Research Institute, Indiana University School of Medicine, Indianapolis, IN RICHARD E. SUTTON•Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX C. SCOTT SWINDLE• Department of Pathology, University of Alabama at Birmingham, Birmingham, AL STEPHEN J. SZILVASSY • Lucille P. Markey Cancer Center, University of Kentucky, Lexington, KY Contributors xi TERRY E. THOMAS•StemCell Technologies Inc., Vancouver, British Columbia, Canada NOBUKO UCHIDA • StemCells Inc., Sunnyvale, CA JAN W. M. VISSER•New York Blood Center, New York, NY SAIPHONE WEBB • Department of Medicine, National Jewish Medical and Research Center, Denver, CO IRVING L. WEISSMAN • Stanford University School of Medicine, Stanford, CA